NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 625817 | Null | 0.0228801759885687 | 0.26136157 |
NSC 653557 | Null | 0.0228801759885687 | 0.31707611 |
NSC 678914 | 4-Acridinecarboxamide, N-[2-(dimethylamino)ethyl]- 1-methoxy-, dihydrochloride | 0.0228801759885687 | 0.22507616 |
NSC 681637 | Camptothecin Derivative | 0.0228801759885687 | 0.34548014 |
NSC 702348 | Null | 0.0228801759885687 | 0.31362301 |
NSC 715755 | Null | 0.0228801759885687 | 0.3520121 |
NSC 716260 | Null | 0.0228801759885687 | 0.1674562 |
NSC 732851 | 1-[3-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-2-chloro-5-trifluoromethylbenzene | 0.0228801759885687 | 0.45326565 |
NSC 742327 | (3-Difluoromethyl-6,7-dimethyl-1,4-dioxy-quinoxalin-2-yl)-phenyl-methanone | 0.0228801759885687 | 0.46443552 |
NSC 744331 | (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd | 0.0228801759885687 | 0.42539117 |